An analysis of Indonesian healthcare workers inoculated with a COVID-19 vaccine developed by China’s Sinovac Biotech showed it was 98 percent effective at preventing death and 96 percent effective at preventing hospitalization, a health ministry official said.
The preliminary study was done from data on healthcare workers in the Indonesian capital Jakarta who had received the CoronaVac vaccine between January and March this year, lead researcher and health official Pandji Dhewantara said on Wednesday.
Europe medicines watchdog begins review of China’s Sinovac vaccineEurope’s medicines watchdog said Tuesday it has started reviewing China’s Sinovac coronavirus jab, a process that could lead to eventual approval for ... Coronavirus
Egypt approves China’s Sinovac COVID-19 vaccine for emergency useEgypt’s drug authority said on Monday it had granted approval to China’s Sinovac coronavirus vaccine for emergency use.For more coronavirus news, ... Coronavirus
Sinovac vaccine may not trigger sufficient antibody response to Brazil variant: StudySinovac Biotech’s COVID-19 vaccine may not trigger sufficient antibody responses against a new variant identified in Brazil, a small-sample lab study ... Coronavirus